PERTOFRANE (DESIPRAMINE HYDROCHLORIDE) — FDA Approval NDA013621 (SANOFI AVENTIS US)
PERTOFRANE (DESIPRAMINE HYDROCHLORIDE) — FDA Approval NDA013621 (SANOFI AVENTIS US) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: PERTOFRANE; Active ingredients: DESIPRAMINE HYDROCHLORIDE; Application number: NDA013621.
| Brand name | PERTOFRANE |
|---|---|
| Active ingredients | DESIPRAMINE HYDROCHLORIDE |
| Application number | NDA013621 |
| Sponsor | SANOFI AVENTIS US |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 19680410 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →